Home > PJ (current issue) > The Society / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7490 p226
23 February 2008


Society summary


Council agrees to postpone creation of emeritus awards until after separation of Society’s functions

The Council of the Royal Pharmaceutical Society has agreed to postpone the creation of emeritus awards until is free from its current regulatory obligations.

At its meeting on the 14 February, the Council was asked whether it wished to “ask the professional body taskforce to develop proposals for an alumni/emeritus offering, as appropriate, as an integral part of the wider work towards a new professional body”.

Presenting a paper to the Council, Christine Gray, head of corporate governance, pointed out that the office had received many comments about the provisions concerning emeritus awards that had been gazetted last autumn (PJ, 13 October 2007, p418). The proposed regulations had stated that the Council might designate any former member who had been a member for 50 years or more as an emeritus member in accordance with procedures determined by the Council from time to time. Emeritus members and fellows would not be allowed to used postnominal letters.

She reminded the Council that the relevant policy decisions on emeritus members had been made in August 2006 before there had been any suggestion that the Society would change its position as a regulator as well as a professional body. She said that, given the adverse comments that had been received from well known members of the profession, going ahead with the awards as currently envisaged, at a time when the Society is still restricted in what it can offer, night seem to give a mixed message to a high-profile, highly respected group within the profession, which would see to go against the Council’s original policy intention.

She recommended to the Council that, in deciding to postpone development of the awards, the Society should make it clear through the pharmacy press that it had listened to members’ concerns and had accordingly decided to rethink the awards in order to make them more meaningful and worthwhile for the recipients. The Council agreed.

In a discussion after the vote, Gerald Alexander asked the President and Chief Executive and Registrar to ask the Pharmacy Regulation and Leadership Oversight Group to look at the registered title of “pharmacist”. He said that the General Pharmaceutical Council would possibly be well advised to refer to “registered pharmacist” as a title. Therefore, other pharmacists who were not registered could refer to themselves as pharmacists.

The postnominals would sit with the professional body, and people would be proud to have those postnominals for the whole period of their existence, from the time they start practising until the time they die. The registered title should be sitting in the Medicines Act. Therefore a “registered pharmacist” would be somebody who is actually practising, and a “pharmacist” would be someone who has actually been a pharmacist and could still remain a pharmacist. But the title needed to be altered in the Medicines Act.

Bob Michell commented: “We are dancing on the head of a pin.” He explained that he was a veterinary surgeon legally and undeniably. He also used “MRCVS” correctly and legally. He explained that if he wrote a prescription and someone wondered who he was, that person could look him up in the register. There it says that he is a veterinary surgeon, but his prescriptions may not be dispensed because he is on the non-practising section of the register. Where is the mystery, where is the confusion, he asked.

The President, Hemant Patel, replied that, in the past, the regulatory role had tied past and present councils’ hands. It was important to have as many pharmacists as members of the Society but legal regulations had meant that it was not possible to have everybody on board.

“We are now seeking ways to try to make sure that everybody who wishes to be a member of the Society and is properly trained to be a pharmacist is included. That is the bottom line message,” he said.

Mrs Gray said that Society could look at what is possible for the future.


Letter to the editor p212

Back to Top


©The Pharmaceutical Journal